Company Quick10K Filing
Weyland Tech
10-Q 2020-09-30 Filed 2020-11-16
10-Q 2020-06-30 Filed 2020-08-14
10-Q 2020-03-31 Filed 2020-05-15
10-K 2019-12-31 Filed 2020-03-30
10-Q 2019-09-30 Filed 2019-11-14
10-Q 2019-06-30 Filed 2019-08-14
10-Q 2019-03-31 Filed 2019-05-15
10-K 2018-12-31 Filed 2019-04-15
S-1 2018-12-17 Public Filing
10-Q 2018-09-30 Filed 2018-11-14
10-Q 2018-06-30 Filed 2018-08-14
10-Q 2018-03-31 Filed 2018-05-15
10-K 2017-12-31 Filed 2018-04-17
10-Q 2017-09-30 Filed 2017-11-14
10-Q 2017-06-30 Filed 2017-08-21
10-Q 2017-03-31 Filed 2017-05-15
10-K 2016-12-31 Filed 2017-03-31
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-06-30 Filed 2016-08-12
10-Q 2016-03-31 Filed 2016-05-23
10-K 2015-12-31 Filed 2016-04-14
10-Q 2015-09-30 Filed 2015-11-23
10-Q 2015-06-30 Filed 2015-08-11
10-Q 2015-03-31 Filed 2015-05-20
10-K 2014-12-31 Filed 2015-04-15
10-Q 2014-09-30 Filed 2014-11-19
10-Q 2014-06-30 Filed 2014-08-12
10-Q 2014-03-31 Filed 2014-05-07
10-K 2013-12-31 Filed 2014-03-27
10-Q 2013-09-30 Filed 2013-11-08
10-Q 2013-06-30 Filed 2013-08-09
10-Q 2013-03-31 Filed 2013-05-10
10-K 2012-12-31 Filed 2013-03-28
10-Q 2012-09-30 Filed 2012-10-22
10-Q 2012-08-08 Filed 2012-08-08
10-Q 2012-03-31 Filed 2012-05-09
10-K 2011-12-31 Filed 2012-03-27
8-K 2020-11-05
8-K 2020-11-04
8-K 2020-10-30
8-K 2020-10-13
8-K 2020-09-30
8-K 2020-09-25
8-K 2020-09-01
8-K 2020-08-28
8-K 2020-08-11
8-K 2020-07-31
8-K 2020-04-16
8-K 2020-03-25
8-K 2020-02-25
8-K 2020-01-08
8-K 2019-12-16
8-K 2019-11-25
8-K 2019-11-15
8-K 2019-08-19
8-K 2019-07-22
8-K 2018-10-05
8-K 2018-09-24
8-K 2018-09-20
8-K 2018-08-16
8-K 2018-02-12

Weyland Tech Financials

WEYL Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
ENETI INC. (NETI)
024 Pharma (EEIG)
Vivus (VVUS) 40,869 77% -17.5 -11% 226,103 289,374 72,620 55,706 -24,956 -13,928 243,484
Clovis Oncology (CLVS) 219,222 0% -0.0 -56% 716,892 804,387 134,050 0 -400,184 -394,255 17,741
Cementos Pacasmayo Saa (CPAC) 4,145,433 0% 2,863,245 1,411,882 0 0 0 0 4,145,433
11 Good Energy (ELVN)
Exantas Capital (XAN)
1347 Capital Corp (TFSC)
Bancorp of New Jersey (BKJ) 122,881 1.0 0% 961,684 868,577 0 0 3,422 14,772 14,360
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
1st Financial Services Corp (FFIS)
1st United Bancorp (FUBC)
2-Track Global (TTG)
ENTERGY ARKANSAS, LLC (EAI)
21st Century Oncology Holdings (RTSX)
24Holdings (TWFH)
30DC (TDCH)
3D Pioneer Systems (DPSM)
ALABAMA POWER CO (APRCP)

Balance Sheet ($'000)2011-06-302011-09-302011-12-312012-03-312012-08-082012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-09-302018-12-312019-03-312019-06-302019-09-30
Cash664059143518306543516504297254304304472002,3801,7639491,0041,3501,2407601,0561,0099407311,3865,3035,821
Accounts Receivable7401,7347370000
Inventory
PP&E8865432210
Assets241347641487724685455175052972543043041686916313,8284,2715,4013,3965,4965,3185,9455,2976,2535,6905,4896,30710,60211,699
Accounts Payable13417341442942940406965270175474218181818888773
Long-Term Debt
Liabilities6003665184844994995124095474824364224054053829148571,9081,4611,8238441,4862,0202,7492,0473,0663093796395,2802,218
Stockholders' Equity-576-353-420-351273-45136-3023-139-169-101-101-214-223-2271,9202,8093,5782,5524,0103,2983,1953,2513,1865,3805,1095,6685,3239,482
Income Statement ($'000)2011-06-302011-09-302011-12-312012-03-312012-08-082012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue8,4368,4927,1428,996
Cost of Revenue3383125881,0181,7621,280629803402244543677969-336475956342,9931,7112,4341,0404,0553,2922,8805121,0336,9845,8747,400
Gross Profit-74272224490-337-209255596-35-99246674-14387551,6271,1401,0681,3351,7973135352,3953,6687,4031,5071,2681,597
R&D1,2094,5118681,2431,126
SG&A21956526423319224315822650425839227847517529514141743252622332512285539062,8784,8226411,6701,558
Tax0
Net Income-224-642-867-246307-639-36527200-290-492-32200-19195-9-91,3709207681,458-23-102-718-507-1,998-27-1,671-1,081
Cash Flow ($'000)2011-06-302011-09-302011-12-312012-03-312012-08-082012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-34935-235-670-5528-147-48-458-435001680-4021,393-700-1,084127-18254-480-89-489692,591-4,722
Cash Investing000-157001630000000-100-60-110-72900000
Cash Financing349020050120322500000001,547-1,1503806573644425861,326